Comparing Crexont vs Rytary
| Crexont (carbidopa / levodopa) | Rytary (carbidopa / levodopa) |
|
|---|
| Crexont (carbidopa / levodopa) | Rytary (carbidopa / levodopa) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Parkinson's Disease. Crexont may also be used for purposes not listed in this medication guide. |
Prescription only
Rytary is an extended-release (long-lasting) medication that may be used for the treatment of Parkinson's disease that is available in four different strengths: Rytary 23.75/95, Rytary 36.25/145... View more |
Related suggestions Parkinson's Disease
|
|||||||||||||||
| More about Crexont (carbidopa / levodopa) | More about Rytary (carbidopa / levodopa) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Be the first to share your experience with this drug. |
Rytary has an average rating of 6.2 out of 10 from a total of 30 ratings on Drugs.com. 53% of reviewers reported a positive effect, while 33% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
|
View all Crexont side effects |
View all Rytary side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Crexont prices |
View all Rytary prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Other carbidopa / levodopa brands include: Atamet, Dhivy, Duopa, Parcopa, Rytary, Sinemet | Other carbidopa / levodopa brands include: Atamet, Crexont, Dhivy, Duopa, Parcopa, Sinemet | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
2.3 hours |
2.3 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 520 drugs are known to interact with Crexont:
|
A total of 520 drugs are known to interact with Rytary:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
August 07, 2024 |
January 07, 2015 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.